@murrayrt
Number of reasons
One was the partial hold on 1102 for MS
Plus the company made it known they would no longer chase the RRMS as the space was overcrowded
So the idea was to do a crossover trial into SPMS which is another unmet field
But to do this because we have no data on SPMS we had to carry a number of RRMS patients along with a number of SPMS to convert the trial over and onto SPMS
Which i am also tipping there could well be something written in the DMD trial along those lines so that we can incorporate the ambulant boys into our DMD programme
Because the advice we are going to get on Monday is basically the guidance and uses market
Back to the RRMS so the trial was going to be to expensive and we redirected into DMD which obviously was the correct move
But if funds eventuate from a deal then this opens up the SPMS route for continuation although a little work to do with the FDA before it could advance
We have the goods i have always believed this
It's not the pipeline I'm worried about its the figures like i said the next move funding wise will determine not when but how fast we join the elite in pharma land
Fingers crossed
See how we go
- Forums
- ASX - By Stock
- Where others have failed will Atl1102 succeed ?
@murrayrt Number of reasons One was the partial hold on 1102 for...
-
- There are more pages in this discussion • 411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $74.82M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.2¢ | $9.57K | 112.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 11000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 0.081 |
4 | 62665 | 0.080 |
1 | 9500 | 0.078 |
2 | 40100 | 0.077 |
1 | 5000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 11000 | 1 |
0.090 | 105882 | 1 |
0.092 | 100000 | 1 |
0.093 | 46625 | 1 |
0.094 | 107837 | 1 |
Last trade - 15.56pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
8.2¢ |
  |
Change
0.002 ( 0.86 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.3¢ | 8.2¢ | 31700 | ||
Last updated 15.55pm 28/03/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online